Potential use of ocular-insert therapy in dry eyes.
D002057:Burns, Chemical / Q000188:drug therapy; D004304:Dosage Forms; D005126:Eye Burns / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy* / Q000209:etiology; D005901:Glaucoma / Q000188:drug therapy; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007065:Idoxuridine / Q000008:administration & dosage; D007635:Keratitis, Dendritic / Q000188:drug therapy; D008722:Methods; D009077:Mucins / Q000378:metabolism; D009883:Ophthalmic Solutions / Q000008:administration & dosage / Q000627:therapeutic use*; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D010862:Pilocarpine / Q000008:administration & dosage / Q000627:therapeutic use; D011108:Polymers / Q000627:therapeutic use; D012636:Secretory Rate; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy; D013666:Tears / Q000378:metabolism; D013997:Time Factors; D014802:Vitamin A Deficiency / Q000150:complications
D004304:Dosage Forms; D009077:Mucins; D009883:Ophthalmic Solutions; D004364:Pharmaceutical Preparations; D011108:Polymers; D010862:Pilocarpine; D007065:Idoxuridine; D006854:Hydrocortisone